Conclusion
In general, regarding different recommendations for corticosteroids use
by various guidelines and authorities, the ultimate decision for
corticosteroid therapy in a COVID-19 patient is primarily based on
physicians’ judgments and the patient’s condition. The application of
corticosteroids requires special attention to the benefit-risk
relationships and the adjustment of doses if necessary. It is mandatory
to monitor signs of hyperglycemia, adrenal insufficiency, and secondary
bacterial and fungal infections in the context of glucocorticoid
therapy.